We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration with Teijin Pharma

News   Jan 12, 2012

 
NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration with Teijin Pharma
 
 
 

RELATED ARTICLES

Antibody Therapy That Trains Phagocytes to Destroy Tumors Is Tested in Patients

News

An immunotherapeutic antibody therapy re-educates macrophages to activate passivated cytotoxic T cells to kill cancer. The antibody therapy prevented the growth of tumors in several mouse models. The development of the therapy has now progressed to patient testing in a phase I/II clinical trial.

READ MORE

New Method to Detect Cancer Cells Faster

News

The days - or even weeks - spent waiting for the results of a cancer-screening test can feel like an eternity. Especially when early diagnosis and quick action are tied to better outcomes. Now, a new technique to analyze proteins expressed on cancer cells shows promise in more rapidly detecting these cell types.

READ MORE

Could a Superior Therapeutic Approach for MS Be on the Horizon?

News

Researchers show compounds based on chloroindazole reduce inflammation as well as promote neuroprotection and remyelination, improving the primary symptoms in a mouse model of multiple sclerosis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Applied Sciences Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE